Page last updated: 2024-10-26

dipyridamole and Orphan Diseases

dipyridamole has been researched along with Orphan Diseases in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Orphan Diseases: Rare diseases that have not been well studied.

Research Excerpts

ExcerptRelevanceReference
" The strict adherence to aspirin and dipyridamole has led to no stroke or progression of the vasculopathy for 8 years."3.73Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia. ( Hara, T; Kira, R; Ohga, S; Sanefuji, M; Torisu, H; Yoshiura, T, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sanefuji, M1
Ohga, S1
Kira, R1
Yoshiura, T1
Torisu, H1
Hara, T1

Other Studies

1 other study available for dipyridamole and Orphan Diseases

ArticleYear
Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia.
    Journal of child neurology, 2006, Volume: 21, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta-Thalassemia; Carotid Arteries; Di

2006